Exploring Fatigue in Parkinson’s Disease: A Comprehensive Literature Review
Open Access
- 25 March 2025
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e81129
Abstract
Fatigue is one of the most prevalent and debilitating non-motor symptoms of Parkinson’s disease (PD), affecting up to two-thirds of patients and significantly impacting quality of life. This review provides a comprehensive analysis of its complex pathophysiology, prevalence, clinical presentation, assessment methods, and current management strategies. Fatigue in PD is linked to dysfunction in dopaminergic and non-dopaminergic pathways, neuroinflammation, genetic predispositions, and metabolic dysregulation. Reported prevalence rates range from 36% to 60%, highlighting the need for standardized assessment tools and a universally accepted definition. Clinically, fatigue is characterized by an overwhelming and abnormal sense of exhaustion, often preceding motor symptoms by years. Distinguishing it from sleepiness, apathy, and depression is crucial for accurate diagnosis and treatment. Assessment primarily relies on patient-reported scales, such as the Fatigue Severity Scale and the Parkinson’s Disease Fatigue Scale. Management includes both pharmacological and non-pharmacological approaches, with medications like methylphenidate and rasagiline showing potential, alongside physical exercise, cognitive behavioral therapy, and sleep disorder management. Further research is essential to unravel the underlying mechanisms, identify objective biomarkers, and develop more effective, targeted treatments for this burdensome symptom.Keywords
All Related Versions
This publication has 144 references indexed in Scilit:
- Acupuncture and Sleep Quality Among Patients With Parkinson DiseaseJAMA Network Open, 2024
- Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variantsAnnals of Clinical and Translational Neurology, 2021
- Cognitive behavioral therapy for anxiety and related disorders: A meta‐analysis of randomized placebo‐controlled trialsDepression and Anxiety, 2018
- Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher RegistryAmerican Journal of Hematology, 2015
- Genomic investigation of α‐synuclein multiplication and parkinsonismAnnals of Neurology, 2008
- Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple SclerosisArchives of Neurology, 2005
- Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover studyMovement Disorders, 2003
- Comorbidity of the nonmotor symptoms of Parkinson's diseaseMovement Disorders, 2001
- Exacerbated physical fatigue and mental fatigue in Parkinson's diseaseMovement Disorders, 2001
- The Fatigue Severity ScaleArchives of Neurology, 1989